Export 45 results:
Author [ Title(Desc)] Type Year
Filters: Author is Barin, B  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
P
N. Terrault, Reddy, K. R., Poordad, F., Curry, M., Schiano, T., Johl, J., Shaikh, O., Dove, L., Shetty, K., Millis, M., Schiff, E., Regenstein, F., Barnes, D., Barin, B., Peters, M., Roland, M., Stock, P., and Investigators, T. H. I. V. T. R., Peginterferon and Ribavirin for Treatment of Recurrent Hepatitis C Disease in HCV-HIV Coinfected Liver Transplant Recipients, Am J Transplant, vol. 14, pp. 1129-1135, 2014.
N. Terrault, Reddy, K. R., Poordad, F., Curry, M., Schiano, T., Johl, J., Shaikh, O., Dove, L., Shetty, K., Millis, M., Schiff, E., Regenstein, F., Barnes, D., Barin, B., Peters, M., Roland, M., and Stock, P., Peginterferon and ribavirin for treatment of recurrent hepatitis C disease in HCV-HIV coinfected liver transplant recipients., Am J Transplant, vol. 14, no. 5, pp. 1129-35, 2014.
S. Mehendale, van Lunzen, J., Clumeck, N., Rockstroh, J., Vets, E., Johnson, P. R., Anklesaria, P., Barin, B., Boaz, M., Kochhar, S., Lehrman, J., Schmidt, C., Peeters, M., Schwarze-Zander, C., Kabamba, K., Glaunsinger, T., Sahay, S., Thakar, M., ,, and Heald, A., A Phase 1 Study to Evaluate the Safety and Immunogenicity of a Recombinant HIV Type 1 Subtype C Adeno-Associated Virus Vaccine, AIDS Research and Human Retroviruses, vol. 24, pp. 873-880, 2008.
E. Vardas, Kaleebu, P., Bekker, L., Hoosen, A., Chomba, E., Johnson, P., Anklesaria, P., Birungi, J., Barin, B., Boaz, M., Cox, J., Lehrman, J., Stevens, G., Gilmour, J., Tarragona, T., Hayes, P., Lowenben, S., Kizito, E., Fast, P., Heald, A., and Schmidt, C., A Phase 2 Study to Evaluate the Safety and Immunogenicity of a Recombinant HIV Type 1 Vaccine Based on Adeno-Associated Virus, AIDS Res Hum Retroviruses, vol. 26, pp. 933-942, 2010.
M. Keefer, Gilmour, J., Hayes, P., Gill, D., Kopycinski, J., Cheeseman, H., Cashin-Cox, M., Naarding, M., Clark, L., Fernandez, N., Bunce, C., Hay, C., Welsh, S., ,, Loughran, K., Barin, B., Cormier, E., Cox, J. H., Fast, P., and Excler, J., A Phase I Double Blind, Placebo-Controlled, Randomized Study of a Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults, PLoS One, vol. 7, p. e41936, 2012.
G. Omosa-Manyonyi, Mpendo, J., Ruzagira, E., Kilembe, W., Chomba, E., Roman, F., Bourguignon, P., Koutsoukos, M., Collard, A., Voss, G., Laufer, D., Stevens, G., Hayes, P., Clark, L., Cormier, E., Dally, L., Barin, B., ,, Gilmour, J., Cox, J., Fast, P., and Priddy, F., A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults, PLoS One, vol. 10, p. e0125954, 2015.
V. Ramanathan, Kumar, M., Mahalingam, J., Narayanan, P., Solomon, S., Boaz, M., Sayeed, E., Scharton-Kersten, T., Seth-Smith, M., Verlinde, C., Vooijs, D., Barin, B., Lombardo, A., Kochhar, S., Excler, J., and Fast, P., A Phase I Study to Evaluate the Safety and Immunogenicity of a Recombinant Modified Vaccinia Ankara Virus (TBC-M4) Multigenic HIV Subtype C Vaccine, in AIDS Vaccine 2007 Conference, Seattle, WA, 2007.
I. U. Ansari, Allen, T., Berical, A., Stock, P. G., Barin, B., and Striker, R., Phenotypic Analysis of NS5A Variant from Liver Transplant Patient with Increased Cyclosporine Susceptibility, Virology, vol. 436, pp. 268-273, 2013.
S
F. M. Kibengo, Ruzagira, E., Katende, D., Bwanika, A. N., Bahemuka, U., Kamali, A., Haberer, J. E., Bangsberg, D. R., Barin, B., Rooney, J. F., Mark, D., Chetty, P., Fast, P., and Priddy, F. H., Safety, Adherence and Acceptability of Intermittent Tenofovir/Emtricitabine as HIV Pre-exposure Prophylaxis (PrEP) among HIV-Uninfected Ugandan Volunteers Living in HIV-Serodiscordant Relationships: A Randomized, Clinical Trial, PLoS One, vol. 8, p. e74314, 2013.
G. Mutua, Sanders, E., Mugo, P., Anzala, O., Haberer, J. E., Bangsberg, D., Barin, B., Rooney, J. F., Mark, D., Chetty, P., Fast, P., and Priddy, F. H., Safety and Adherence to Intermittent Pre-Exposure Prophylaxis (PrEP) for HIV-1 in African Men Who Have Sex with Men and Female Sex Workers, PLoS One, vol. 7, p. e33103, 2012.
J. W, FN, N., O, A., G, O. Manyonyi, J, B., A, N., F, B., K, B., H, O., S, W., L, M., W, W., J, O., M, O., J, I., J, N. - A., C, K., ,, Smith, C., Barin, B., Dally, L., ,, and Kaleebu, P., Safety and Immunogenicity of Recombinant Low-Dosage HIV-1 A Vaccine Candidates Vectored by Plasmid pTHr DNA or Modified Vaccinia Virus Ankara (MVA) in Humans in East Africa, Vaccine, vol. 26, pp. 2788-2795, 2008.
B. S. Peters, Jaoko, W., Vardas, E., Panayotakopoulos, G., Fast, P., Schmidt, C., Gilmour, J., Bogoshi, M., G Manyonyi, O., Dally, L., Klavinskis, L., Farah, B., Tarragona, T., Bart, P. - A., Robinson, A., Pieterse, C., Stevens, W., Thomas, R., Barin, B., and Bwayo, J. [..], Studies of a Prophylactic HIV-1 Vaccine Candidate Based on Modified Vaccinia Virus Ankara (MVA) with and without DNA Priming: Effects of Dosage and Route on Safety and Immunogenicity, Vaccine, vol. 25, pp. 2120-2127, 2007.
J. Harbell, Fung, J., Nissen, N., Olthoff, K., Florman, S., Hanto, D., Light, J., Bartlett, S., Tzakis, A., Pearson, T., Barin, B., Roland, M., and Stock, P., Surgical Complications in 275 HIV-Infected Liver and/or Kidney Transplantation Recipients, Surgery, vol. 152, pp. 376-381, 2012.